US EditionCost of weight-loss drug Mounjaro to be discounted in UK pharmacies when price hike comes into force, Sky News learns
Second Nature will absorb the cost increase for September to prevent treatment disruption for current Mounjaro users amid a 170% price rise by Eli Lilly.
- Eli Lilly confirmed that the price of the weight-loss drug Mounjaro will rise sharply from September 1 across all dosages in the UK.
- This increase follows background pressure from US complaints about medicine pricing and a surge in demand amid soaring obesity levels affecting over a quarter of British adults.
- In response, Second Nature and some providers pledged a September price freeze for existing patients while urging caution against unregulated sellers distributing unsafe counterfeit medications.
- The top dose of Mounjaro will double in price from £122 to £247.50 monthly, but Second Nature will absorb short-term costs to maintain access and support dose adjustments to manage affordability.
- Experts warn the price rise may force private patients to abandon treatment and shift to NHS services, increasing strain and potentially worsening obesity outcomes across the UK.
Insights by Ground AI
Does this summary seem wrong?
32 Articles
32 Articles
Coverage Details
Total News Sources32
Leaning Left4Leaning Right1Center19Last UpdatedBias Distribution79% Center
Bias Distribution
- 79% of the sources are Center
79% Center
L 17%
C 79%
Factuality
To view factuality data please Upgrade to Premium
